CARNEGIE MELLON UNIVERSITY - Q1 2022 holdings

$239 Million is the total value of CARNEGIE MELLON UNIVERSITY's 6 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
IEMG BuyISHARES INCcore msci emkt$162,035,000
+5.9%
2,916,918
+14.1%
67.78%
+10.7%
SellDUOLINGO INC$74,661,000
-20.0%
785,000
-10.7%
31.23%
-16.3%
NBSE  NEUBASE THERAPEUTICS INC$1,766,000
-33.1%
939,4120.0%0.74%
-30.0%
VERA SellVERA THERAPEUTICS INCcl a$377,000
-56.1%
16,060
-50.0%
0.16%
-53.9%
 PREDICTIVE ONCOLOGY INC$202,000
+2.5%
207,1440.0%0.08%
+6.3%
IHT  INNSUITES HOSPITALITY TRsh ben int$31,000
+40.9%
10,0000.0%0.01%
+44.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES INC8Q3 202379.8%
DUOLINGO INC8Q3 202377.3%
NEUBASE THERAPEUTICS INC.8Q3 20231.1%
VERA THERAPEUTICS INC.8Q3 20230.4%
PREDICTIVE ONCOLOGY INC.8Q3 20230.1%
INNSUITES HOSPITALITY TRUST8Q3 20230.0%
CARMELL THERAPEUTICS CORP1Q3 20230.5%

View CARNEGIE MELLON UNIVERSITY's complete holdings history.

Latest significant ownerships (13-D/G)
CARNEGIE MELLON UNIVERSITY Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NeuBase Therapeutics, Inc.July 22, 2019939,4125.5%

View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-01
13F-HR2023-08-01
13F-HR2023-05-03
13F-HR2023-02-07
13F-HR2022-11-10
13F-HR2022-08-05
13F-HR2022-05-10
13F-HR2022-02-11
SC 13G2019-07-22

View CARNEGIE MELLON UNIVERSITY's complete filings history.

Compare quarters

Export CARNEGIE MELLON UNIVERSITY's holdings